WELLINGTON MANAGEMENT GROUP LLP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$210,420,282
+14.3%
13,258,997
+35.9%
0.04%
+20.0%
Q2 2023$184,037,203
+385.8%
9,752,899
-1.1%
0.04%
+337.5%
Q1 2023$37,880,774
-17.2%
9,864,785
+6.9%
0.01%
-11.1%
Q4 2022$45,764,472
-4.3%
9,226,708
-7.8%
0.01%
-10.0%
Q3 2022$47,835,000
-0.8%
10,007,505
-6.6%
0.01%0.0%
Q2 2022$48,227,000
-22.4%
10,717,085
-18.0%
0.01%
-9.1%
Q1 2022$62,182,000
-39.7%
13,063,484
-6.0%
0.01%
-31.2%
Q4 2021$103,157,000
+29.3%
13,902,498
-1.2%
0.02%
+14.3%
Q3 2021$79,765,000
-17.1%
14,068,108
-3.6%
0.01%
-12.5%
Q2 2021$96,166,000
-37.5%
14,592,570
-23.2%
0.02%
-40.7%
Q1 2021$153,928,000
+8.1%
19,003,480
-13.9%
0.03%
+3.8%
Q4 2020$142,442,000
+71.4%
22,084,103
-4.3%
0.03%
+52.9%
Q3 2020$83,089,000
-22.5%
23,080,128
-1.0%
0.02%
-29.2%
Q2 2020$107,233,000
+64.2%
23,311,638
+21.7%
0.02%
+41.2%
Q1 2020$65,305,000
+30559.6%
19,151,382
+45818.9%
0.02%
Q4 2019$213,000
-49.6%
41,707
-78.6%
0.00%
Q2 2019$423,000
+274.3%
194,701
+366.8%
0.00%
Q1 2019$113,000
-38.9%
41,710
+114.0%
0.00%
Q3 2018$185,000
-92.3%
19,495
-92.1%
0.00%
-100.0%
Q2 2018$2,408,000
+12.9%
247,496
+22.1%
0.00%
Q1 2018$2,133,000
-18.2%
202,738
-50.1%
0.00%
-100.0%
Q4 2017$2,607,000
+9.3%
406,661
+30.4%
0.00%0.0%
Q3 2017$2,385,000
+387.7%
311,763
+70.7%
0.00%
Q3 2016$489,000
-46.0%
182,591
-37.9%
0.00%
Q2 2016$905,000
-62.0%
293,899
+5.1%
0.00%
-100.0%
Q1 2016$2,383,000
-20.0%
279,713
+27.5%
0.00%0.0%
Q4 2015$2,977,000
-55.6%
219,386
-65.4%
0.00%
-50.0%
Q3 2014$6,706,000
-56.7%
633,248
-51.6%
0.00%
-50.0%
Q2 2014$15,495,000
-66.8%
1,307,500
-58.2%
0.00%
-69.2%
Q1 2014$46,679,000
+0.0%
3,126,551
-1.7%
0.01%0.0%
Q4 2013$46,661,000
-18.3%
3,180,697
-5.3%
0.01%
-27.8%
Q3 2013$57,145,000
-2.4%
3,357,517
-4.8%
0.02%
-5.3%
Q2 2013$58,533,0003,528,1920.02%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders